Professor Haitham Tuffaha
Professor
Centre for the Business and Economics of Health
I am a Professorial Research Fellow at The University of Queensland’s Centre for the Business and Economics of Health (CBEH), where I lead the Effective and Efficient Healthcare program. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical Benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research. From late 2022 to November 2024, I served as Interim Director of CBEH.
I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $30 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.
I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology Group, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.
Research interests
Health technology assessment: comprehensive assessment of the safety, efficacy and cost-effectiveness of new health interventions.
Value of information analysis: estimating the health and monetary gain from conducting clinical trials and cohort studies.
Cancer economics: evaluating the health and economic impact of interventions for cancer prevention, early detection, management, and survivorship.
Research impact
My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.
I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.
Contact
To find out how we can collaborate and bring value to your organisation, I can be contacted via:
Email - h.tuffaha@uq.edu.au
Connect with Haitham on LinkedIn
Featured projects
| Project title | Funding amount | Duration |
|---|---|---|
| ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals | $5 million | 2023-2028 |
| Medical Services Advisory Committee assessment unit Commonwealth Department of Health | Confidential | 2023 - 2025 |
| Pharmaceutical Benefits Advisory Committee assessment unit Commonwealth Department of Health | Confidential | 2021 - 2025 |
| Health economics analysis of animal plasma-derived antivenoms and antivenom distribution pathways for sub-Saharan Africa World Health Organisation (WHO) | $180k | 2023-2024 |
| Research Alliance for Value-Based Care in Interventional Radiology Terumo and Stryker Australia Pty Ltd | $150k | 2022-2024 |
| Prostate Cancer Survivorship Essentials for Men with Prostate Cancer on Androgen Deprivation Therapy: Transforming Care to Improve Outcomes NHRMC Partnership | $2.5 million | 2021 - 2025 |
| Enhancing treatment outcomes after gynaecological cancer (ACUMEN): Using exercise to promote health after cancer therapy MRFF- Rare Cancers, Rare Diseases and Unmet need | $2.2m | 2020 - 2023 |
Publications
Book Chapters
Jackson, Christopher, Jalal, Hawre, Heath, Anna, Kunst, Natalia, Thom, Howard, Welton, Nicky J., Tuffaha, Haitham and Wilson, Edward C. F. (2024). The expected value of perfect or partial perfect information. Value of information for healthcare decision-making. (pp. 47-91) edited by Anna Heath, Natalia Kuns and Christopher Jackson. Boca Raton, FL, United States: Chapman and Hall/CRC. doi: 10.1201/9781003156109-3
Kunst, Natalia, Wilson, Edward C. F., Tuffaha, Haitham, Jackson, Christopher, Welton, Nicky J., Jalal, Hawre and Alarid-Escudero, Fernando (2024). Value of information: success stories. Value of information for healthcare decision-making. (pp. 193-206) edited by Anna Heath, Natalia Kuns and Christopher Jackson. Boca Raton, FL, United States: Chapman and Hall/CRC. doi: 10.1201/9781003156109-6
Kunst, Natalia, Wilson, Edward C. F., Tuffaha, Haitham, Jackson, Christopher, Welton, Nicky J., Jalal, Hawre and Alarid-Escudero, Fernando (2024). Value of information: success stories. Value of information for healthcare decision-making. (pp. 193-205) edited by Anna Heath, Natalia Kunst and Christopher Jackson. Boca Raton, FL, United States: CRC Press. doi: 10.1201/9781003156109
Journal Articles
Wang, Yufan, McCarthy, Alexandra L. and Tuffaha, Haitham (2025). Co-designing a structured expert elicitation with clinicians to enhance health care decision making in exercise oncology. Medical Decision Making. doi: 10.1177/0272989x251332967
Roberts, Matthew J., Arora, Shiksha, Yao, Henry H., Hogan, Donnacha, Dias, Brendan, O'Connell, Helen E., Wetherell, David, Zargar, Homayoun, Kwok, Michael, McGeorge, Stephen P., Pearce, Adam, Yaxley, John and Tuffaha, Haitham (2025). Transperineal prostate biopsy under local vs general anaesthesia: a cost-effectiveness analysis. BJU international, 1-7. doi: 10.1111/bju.16722
Cunningham, Brent, Porter-Steele, Janine, Hayes, Sandra C., Chiu, Vivian, Clifford, Briana K., Rose, Grace L., Jones, Caroline L., Bailey, Tom G., Young, Leonie, Garrett, Andrea, Nicklin, James, Khan, Asaduzzaman, Tuffaha, Haitham and McCarthy, Alexandra L. (2025). Telehealth-Delivered Exercise to Promote Health after Gynecological Cancer Therapy: A Randomized Waitlist-Controlled Trial. Translational Journal of the American College of Sports Medicine, 10 (2) e000307, 1-6. doi: 10.1249/tjx.0000000000000307
Pak, Anton, O'Grady, Madeline, Holtmann, Gerald, Shah, Ayesha and Tuffaha, Haitham (2025). Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review. PharmacoEconomics, 43 (3) e14578, 249-269. doi: 10.1007/s40273-024-01455-y
Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019
Ferris, Laura J., Ludlow, Kristiana, Walker, Nicole, Georgiou, Andrew, Henry, Julie D., Lopez Silva, Claudia, Ha, Diep H., Stormon, Nicole, Walsh, Laurence J., Ivanovski, Saso, Sexton, Christopher, Silveira Schuch, Helena, Tuffaha, Haitham, Zamora, Angelique, Pritchard, Lyndal and Do, Loc G. (2024). Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol. Healthcare, 12 (19) 1953, 1-10. doi: 10.3390/healthcare12191953
Pak, Anton, Pols, Thomas, Kondalsamy-Chennakesavan, Srinivas, McGrail, Matthew, Gurney, Tiana, Fox, Jordan L. and Tuffaha, Haitham (2024). A preference-based value framework to assess healthcare provision in an oil and gas industry. Australian Health Review, 48 (5), 524-529. doi: 10.1071/ah24111
Heneka, Nicole, Chambers, Suzanne K., Schaefer, Isabelle, Carmont, Kelly, Parcell, Melinda, Wallis, Shannon, Walker, Stephen, Tuffaha, Haitham, Steele, Michael and Dunn, Jeff (2024). Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot. Australian Journal of Rural Health, 32 (4), 815-826. doi: 10.1111/ajr.13149
Teppala, Srinivas, Scuffham, Paul A. and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer. International Journal of Technology Assessment in Health Care, 40 (1) e14, 1-9. doi: 10.1017/s0266462324000011
Green, Anna, Newton, Robert U, Smith, David P, Tuffaha, Haitham, Galvão, Daniel A, Heathcote, Peter, Patel, Manish I, Christie, David, Egger, Sam, Sara, Sally AM, Heneka, Nicole, Chambers, Suzanne K and Dunn, Jeff (2024). Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). BMJ Open, 14 (3) e084412, 1-9. doi: 10.1136/bmjopen-2024-084412
Arora, Shiksha and Tuffaha, Haitham (2024). Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India. Asia-Pacific Journal of Clinical Oncology, 20 (1), 55-62. doi: 10.1111/ajco.13962
Tuffaha, Haitham, Edmunds, Kim, Fairbairn, David, Roberts, Matthew J., Chambers, Suzanne, Smith, David P, Horvath, Lisa, Arora, Shiksha and Scuffham, Paul (2024). Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer and Prostatic Diseases, 27 (4), 594-603. doi: 10.1038/s41391-023-00676-0
Taylor, William J., Tuffaha, Haitham, Hawley, Carmel M., Peyton, Philip, Higgins, Alisa M., Scuffham, Paul A., Nemeh, Fiona, Balagurunathan, Anitha, Hansen, Paul, Jacques, Angela and Morton, Rachael L. (2023). Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals. PLoS One, 18 (12) e0295304, 1-12. doi: 10.1371/journal.pone.0295304
Modi, Natansh D., Kichenadasse, Ganessan, Hoffmann, Tammy C., Haseloff, Mark, Logan, Jessica M., Veroniki, Areti A., Venchiarutti, Rebecca L., Smit, Amelia K., Tuffaha, Haitham, Jayasekara, Harindra, Manning-Bennet, Arkady, Morton, Erin, McKinnon, Ross A., Rowland, Andrew, Sorich, Michael J. and Hopkins, Ashley M. (2023). A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC Medicine, 21 (1) 400, 400. doi: 10.1186/s12916-023-03113-0
Fox, Jordan L., Gurney, Tiana, Kondalsamy-Chennakesavan, Srinivas, Pols, Thomas A. H., Tuffaha, Haitham, Pak, Anton and McGrail, Matthew (2023). A narrative review of health status and healthcare delivery in the oil and gas industry: impacts on employees, employers, and local communities. Healthcare, 11 (21) 2888, 1-17. doi: 10.3390/healthcare11212888
Gough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Schreiber, Veronika, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron E. (2023). Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. Histopathology, 83 (4), 647-656. doi: 10.1111/his.15000
Wang, Yufan, McCarthy, Alexandra L., Hayes, Sandra C., Gordon, Louisa G., Chiu, Vivian, Bailey, Tom G., Stewart, Elizabeth and Tuffaha, Haitham (2023). Economic evaluation of exercise interventions for individuals with cancer: a systematic review. Preventive Medicine, 172 107491, 1-8. doi: 10.1016/j.ypmed.2023.107491
Niknam, Fatemeh, Sharifian, Roxana, Bashiri, Azadeh, Mardani, Maryam, Akbari, Reza, Tuffaha, Haitham, Do, Loc and Bastani, Peivand (2023). Tele-dentistry, its trends, scope, and future framework in oral medicine; a scoping review during January 1999 to December 2021. Archives of Public Health, 81 (1) 104, 1-14. doi: 10.1186/s13690-023-01128-w
Wang, Yufan, McCarthy, Alexandra L and Tuffaha, Haitham (2023). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. Supportive Care in Cancer, 31 (7) 391, 391. doi: 10.1007/s00520-023-07819-y
Delaforce, Alana, Farmer, Shannon, Duff, Jed, Munday, Judy, Miller, Kristin, Glover, Lynne, Corney, Chris, Ansell, Gareth, Gutta, Naadir, Tuffaha, Haitham, Hardy, Janet and Hurst, Cameron (2023). Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway. Transfusion, 63 (4), 724-736. doi: 10.1111/trf.17287
Teppala, Srinivas, Hodgkinson, Brent, Hayes, Sandi, Scuffham, Paul and Tuffaha, Haitham (2023). A review of the cost-effectiveness of genetic testing for germline variants in familial cancer. Journal of Medical Economics, 26 (1), 19-33. doi: 10.1080/13696998.2022.2152233
Morton, Rachael L., Tuffaha, Haitham, Blaya-Novakova, Vendula, Spencer, Jenean, Hawley, Carmel M., Peyton, Phil, Higgins, Alisa, Marsh, Julie, Taylor, William J., Huckson, Sue, Sillett, Amy, Schneemann, Kieran, Balagurunanthan, Anitha, Cumpston, Miranda, Scuffham, Paul A., Glasziou, Paul and Simes, Robert J. (2022). Approaches to prioritising research for clinical trial networks: a scoping review. Trials, 23 (1) 1000, 1-21. doi: 10.1186/s13063-022-06928-z
Edmunds, Kim, Scuffham, Paul, Newton, Robert U., Galvão, Daniel A. and Tuffaha, Haitham (2022). Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis. Supportive Care in Cancer, 30 (6), 5037-5046. doi: 10.1007/s00520-022-06900-2
Maraiki, Fatma, Bazarbashi, Shouki, Scuffham, Paul and Tuffaha, Haitham (2022). Methodological approaches to cost-effectiveness analysis in Saudi Arabia: what can we learn? a systematic review. MDM Policy and Practice, 7 (1) 23814683221086869, 1-11. doi: 10.1177/23814683221086869
Wubishet, Befikadu L., Tesfaye, Wubshet H., Khan, Md Nuruzzaman, Thomas, Jackson, Tuffaha, Haitham, Comans, Tracy A., Scuffham, Paul and Erku, Daniel A. (2021). Public hesitancy to COVID‐19 vaccine and the role of pharmacists in addressing the problem and improving uptake. Journal of Pharmacy Practice and Research, 51 (6), 494-500. doi: 10.1002/jppr.1784
Newall, A.T., Beutels, P., Tuffaha, H.W., Hall, P.S. and Jit, M. (2021). How can early stage economic evaluation help guide research for future vaccines?. Vaccine, 40 (2), 175-177. doi: 10.1016/j.vaccine.2021.11.017
Treish, Imad, Al Rabayah, Abeer, Jaddoua, Saad and Tuffaha, Haitham (2021). Impact of a new cost-effectiveness threshold implementation on cancer formulary decisions in Jordan. PharmacoEconomics - Open, 6 (2), 137-145. doi: 10.1007/s41669-021-00293-4
Edbrooke, Lara, Denehy, Linda, Patrick, Cameron and Tuffaha, Haitham (2021). Cost‐effectiveness analysis of home‐based rehabilitation compared to usual care for people with inoperable lung cancer. European Journal of Cancer Care, 30 (6) ecc.13501, 1-11. doi: 10.1111/ecc.13501
Athanasiou, Christos, Mallidis, Evangelos and Tuffaha, Hussein (2021). Comparative effectiveness of different localization techniques for non-palpable breast cancer. A systematic review and network meta-analysis. European Journal of Surgical Oncology, 48 (1), 53-59. doi: 10.1016/j.ejso.2021.10.001
El-Saifi, Najwan N. F., Moyle, Wendy, Jones, Cindy J. and Tuffaha, Haitham W. A. (2021). The perceptions of informal carers of older people with dementia about the role of their pharmacists. International Journal of Pharmacy Practice, 29 (5), 465-470. doi: 10.1093/ijpp/riab040
Edmunds, Kim, Scuffham, Paul, Reeves, Penny, Galvão, Daniel A., Taaffe, Dennis R., Newton, Robert U., Spry, Nigel, Joseph, David and Tuffaha, Haitham (2021). Demonstrating the value of early economic evaluation alongside clinical trials: Exercise medicine for men with metastatic prostate cancer. European Journal of Cancer Care, 30 (5) e13479, e13479. doi: 10.1111/ecc.13479
Tuffaha, Haitham, Rothery, Claire, Kunst, Natalia, Jackson, Chris, Strong, Mark and Birch, Stephen (2021). A Review of Web-Based Tools for Value-of-Information Analysis. Applied Health Economics and Health Policy, 19 (5), 645-651. doi: 10.1007/s40258-021-00662-4
Delaforce, Alana, Duff, Jed, Munday, Judy, Farmer, Shannon, Miller, Kristin, Glover, Lynne, Corney, Christopher, Hurst, Cameron, Ansell, Gareth, Gutta, Naadir, Tuffaha, Haitham and Hardy, Janet (2021). A theoretically informed approach to support the implementation of pre-operative anemia and iron deficiency screening, evaluation, and management pathways: protocol for a type two hybrid-effectiveness study. Journal of Multidisciplinary Healthcare, 14, 1037-1044. doi: 10.2147/jmdh.s313309
Mashni, Ola K., Nazer, Lama H., Khalil, Haya Z., Dalbah, Maha I., Tuffaha, Haitham W., Rumman, Asma T. and Jaddoua, Saad M. (2021). Impact of clinical pharmacy services on patient management in the chemotherapy infusion clinics: a 5-year study at a comprehensive cancer center. Journal of Pharmacy Practice, 35 (5), 1-5. doi: 10.1177/08971900211003446
Tuffaha, Haitham (2020). Value of information analysis: are we there yet?. PharmacoEconomics - Open, 5 (2), 139-141. doi: 10.1007/s41669-020-00227-6
Edmunds, Kim, Tuffaha, Haitham, Scuffham, Paul, Galvão, Daniel A. and Newton, Robert U. (2020). The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review. Supportive Care in Cancer, 28 (12), 5661-5671. doi: 10.1007/s00520-020-05637-0
Edmunds, Kim, Reeves, Penny, Scuffham, Paul, Galvao, Daniel A., Newton, Robert U., Jones, Mark, Spry, Nigel, Taaffe, Dennis R., Joseph, David, Chambers, Suzanne K. and Tuffaha, Haitham (2020). Cost-effectiveness analysis of supervised exercise training in men with prostate cancer previously treated with radiation therapy and androgen-deprivation therapy. Applied Health Economics and Health Policy, 18 (5), 727-737. doi: 10.1007/s40258-020-00564-x
Edmunds, Kim, Tuffaha, Haitham, Galvão, Daniel A., Scuffham, Paul and Newton, Robert U. (2020). Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review. Supportive Care in Cancer, 28 (5), 2079-2093. doi: 10.1007/s00520-019-05255-5
Muir, Rachel, Carlini, Joan Julie, Harbeck, Emma Louise, Gillespie, Brigid Mary, Tuffaha, Haitham Wadah, Walker, Rachel Michell, McInnes, Elizabeth Catherine, Latimer, Sharon Leanne, Lin, Frances Fengzhi, Pearcy, Josh Michael and Chaboyer, Wendy Pearl (2020). Patient involvement in surgical wound care research: A scoping review. International Wound Journal, 17 (5) iwj.13395, 1462-1482. doi: 10.1111/iwj.13395
Green, Heather J., Mihuta, Mary E., Ownsworth, Tamara, Dhillon, Haryana M., Tefay, Merilyn, Sanmugarajah, Jasotha, Tuffaha, Haitham W., Ng, Shu‐Kay and Shum, David H.K. (2019). Adaptations to cognitive problems reported by breast cancer survivors seeking cognitive rehabilitation: a qualitative study. Psycho-Oncology, 28 (10), 2042-2048. doi: 10.1002/pon.5189
El‐Saifi, Najwan, Moyle, Wendy, Jones, Cindy J. and Tuffaha, Haitham W. (2019). Improving medication adherence in people with dementia through a technological design. Journal of Pharmacy Practice and Research, 49 (5), 482-485. doi: 10.1002/jppr.1551
Tuffaha, Haitham W., Aitken, Joanne, Chambers, Suzanne and Scuffham, Paul A. (2019). A framework to prioritise health research proposals for funding: integrating value for money. Applied Health Economics and Health Policy, 17 (6), 761-770. doi: 10.1007/s40258-019-00495-2
Maraiki, Fatma, Byrnes, J., Tuffaha, H. and Hinder, M. (2019). International HTA experience with targeted therapy approvals for lung cancer. PharmacoEconomics - Open, 3 (1), 103-117. doi: 10.1007/s41669-018-0088-x
Tuffaha, Haitham, El-Saifi, Najwan, Chambers, Suzanne and Scuffham, Paul (2019). New challenges in psycho-oncology: economic evaluation of psychosocial services in cancer: challenges and best practice recommendations. Psycho-Oncology, 28 (1), 3-10. doi: 10.1002/pon.4933
Tuffaha, Haitham W., El Saifi, Najwan, Chambers, Suzanne K. and Scuffham, Paul A. (2018). Directing research funds to the right research projects: a review of criteria used by research organisations in Australia in prioritising health research projects for funding. BMJ Open, 8 (12) e026207, e026207. doi: 10.1136/bmjopen-2018-026207
Tuffaha, Haitham W., Marsh, Nicole, Byrnes, Joshua, Gavin, Nicole, Webster, Joan, Cooke, Marie and Rickard, Claire M. (2018). Cost of vascular access devices in public hospitals in Queensland. Australian Health Review, 43 (5), 511-515. doi: 10.1071/AH18102
Rickard, Claire M., Marsh, Nicole, Webster, Joan, Runnegar, Naomi, Larsen, Emily, McGrail, Matthew R., Fullerton, Fiona, Bettington, Emilie, Whitty, Jennifer A., Abu Choudhury, Md, Tuffaha, Haitham, Corley, Amanda, McMillan, David J., Fraser, John F., Marshall, Andrea P. and Playford, E. Geoffrey (2018). Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. Lancet, 392 (10145), 419-430. doi: 10.1016/S0140-6736(18)31380-1
El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Medication adherence in older patients with dementia: a systematic literature review. Journal of Pharmacy Practice, 31 (3), 322-334. doi: 10.1177/0897190017710524
Tuffaha, Haitham W. and Scuffham, Paul A. (2018). The Australian managed entry scheme: are we getting it right?. Pharmacoeconomics, 36 (5), 555-565. doi: 10.1007/s40273-018-0633-6
Gordon, Louisa G., Tuffaha, Haitham W., James, Robbie, Keller, Andrew T., Lowe, Anthony, Scuffham, Paul A. and Gardiner, Robert A. (2018). Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis. Urologic Oncology, 36 (3) 91.e7, e7-e15. doi: 10.1016/j.urolonc.2017.10.024
Tuffaha, Haitham W., Mitchell, Andrew, Ward, Robyn L., Connelly, Luke, Butler, James R. G., Norris, Sarah and Scuffham, Paul A. (2018). Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 20 (9), 985-994. doi: 10.1038/gim.2017.231
Nazer, Lama H., Tuffaha, Haitham and Jaddoua, Saad (2017). A program to increase research productivity among hospital pharmacists. Journal of Pharmacy Practice, 30 (3), 336-341. doi: 10.1177/0897190016645432
Gordon, Louisa G., James, Robbie, Tuffaha, Haitham W., Lowe, Anthony and Yaxley, John (2017). Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. Journal of Magnetic Resonance Imaging, 45 (5), 1304-1315. doi: 10.1002/jmri.25504
Nazer, Lama H. and Tuffaha, Haitham (2017). Health care and pharmacy practice in Jordan. Canadian Journal of Hospital Pharmacy, 70 (2), 150-155. doi: 10.4212/cjhp.v70i2.1649
Tuffaha, Haitham W., Andronis, Lazaros and Scuffham, Paul A. (2017). Setting medical research future fund priorities: assessing the value of research. Medical Journal of Australia, 206 (2), 64-65.e1. doi: 10.5694/mja16.00672
Ball, Lauren, Lee, Patricia, Ambrosini, Gina L., Hamilton, Kyra and Tuffaha, Haitham (2016). How often should general practitioners provide nutrition care to patients? A forecasting activity to determine the target frequency for chronic-disease management in Australia. Australian Journal of Primary Health, 22 (5), 383-387. doi: 10.1071/py16060
Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2016). Value of information analysis informing adoption and research decisions in a portfolio of health care interventions. MDM Policy & Practice, 1 (1), 238146831664223. doi: 10.1177/2381468316642238
Tuffaha, Haitham W., Roberts, Shelley, Chaboyer, Wendy, Gordon, Louisa G. and Scuffham, Paul A. (2016). Cost-effectiveness analysis of nutritional support for the prevention of pressure ulcers in high-risk hospitalized patients. Advances in Skin and Wound Care, 29 (6), 261-267. doi: 10.1097/01.ASW.0000482992.87682.4c
Tuffaha, Haitham W., Strong, Mark, Gordon, Louisa G. and Scuffham, Paul A. (2016). Efficient value of information calculation using a nonparametric regression approach: an applied perspective. Value in Health, 19 (4), 505-509. doi: 10.1016/j.jval.2016.01.011
El-Saifi, N., Moyle, W., Jones, C. and Tuffaha, H. (2016). Quetiapine safety in older adults: a systematic literature review. Journal of Clinical Pharmacy and Therapeutics, 41 (1), 7-18. doi: 10.1111/jcpt.12357
Tuffaha, Haitham W., Gillespie, Brigid M., Chaboyer, Wendy, Gordon, Louisa G. and Scuffham, Paul A. (2015). Cost-utility analysis of negative pressure wound therapy in high-risk cesarean section wounds. Journal of Surgical Research, 195 (2), 612-622. doi: 10.1016/j.jss.2015.02.008
Tuffaha, Haitham W., Roberts, Shelley, Chaboyer, Wendy, Gordon, Louisa G. and Scuffham, Paul A. (2015). Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later. Applied Health Economics and Health Policy, 13 (2), 167-179. doi: 10.1007/s40258-015-0152-y
Reynolds, Heather, Taraporewalla, Kersi, Tower, Marion, Mihala, Gabor, Tuffaha, Haitham W., Fraser, John F. and Rickard, Claire M. (2015). Novel technologies can provide effective dressing and securement for peripheral arterial catheters: a pilot randomised controlled trial in the operating theatre and the intensive care unit. Australian Critical Care, 28 (3), 140-148. doi: 10.1016/j.aucc.2014.12.001
Tuffaha, Haitham W., Reynolds, Heather, Gordon, Louisa G., Rickard, Claire M. and Scuffham, Paul A. (2014). Value of information analysis optimizing future trial design from a pilot study on catheter securement devices. Clinical Trials, 11 (6), 648-656. doi: 10.1177/1740774514545634
Tuffaha, H. W., Rickard, C. M., Inwood, S., Gordon, L. and Scuffham, P. (2014). The epic3 recommendation that clinically indicated replacement of peripheral venous catheters is safe and cost-saving: how much would the NHS save?. Journal of Hospital Infection, 87 (3), 183-184. doi: 10.1016/j.jhin.2014.04.004
Abdel-Rahman, Fawzi, Tuffaha, Haitham W, Sharma, Shanta, Jazar, Husam Abu, Hussein, Nilly, Saad, Adnan, Al Rawi, Omar and Hussein, Ayad (2014). GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis. Journal of Oncology Pharmacy Practice, 20 (2), 130-136. doi: 10.1177/1078155213484785
Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2014). Value of information analysis in healthcare: a review of principles and applications. Journal of Medical Economics, 17 (6), 377-383. doi: 10.3111/13696998.2014.907170
Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2014). Value of information analysis in oncology: the value of evidence and evidence of value. Journal of Oncology Practice, 10 (2), e55-e62. doi: 10.1200/JOP.2013.001108
Tuffaha, Haitham W., Rickard, Claire M., Webster, Joan, Marsh, Nicole, Gordon, Louisa, Wallis, Marianne and Scuffham, Paul A. (2014). Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters. Applied Health Economics and Health Policy, 12 (1), 51-58. doi: 10.1007/s40258-013-0077-2
Salmany, Sewar S., Koopmans, Sara M., Treish, Imad M., El Jaber, Rana, Telfah, Shorouq and Tuffaha, Haitham W. (2012). Revision and validation of a medication assessment tool for chronic cancer pain management. The American Journal of Hospice and Palliative Medicine, 29 (8), 640-646. doi: 10.1177/1049909111435812
Tuffaha, H. W. and Al Omar, S. (2012). Glucarpidase for the treatment of life-threatening methotrexate overdose. Drugs of Today, 48 (11), 705-711. doi: 10.1358/dot.2012.48.11.1871575
Tuffaha, Haitham W and Koopmans, Sara M (2012). Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. Journal of Oncology Pharmacy Practice, 18 (2), 180-185. doi: 10.1177/1078155211416529
Tuffaha, Haitham W., Abdelhadi, Ola and Al Omar, Suha (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. International Journal of Clinical Pharmacy, 34 (1), 27-31. doi: 10.1007/s11096-011-9600-4
Tuffaha, Haitham W and Al Omar, Suha (2011). Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Journal of Oncology Pharmacy Practice, 17 (2), 136-40. doi: 10.1177/1078155209348720
Tuffaha, Haitham and Abdel-Rahman, Fawzi Abdel-Latif (2010). Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor. Hematology/ Oncology and Stem Cell Therapy, 3 (4), 203-205. doi: 10.5144/1658-3876.2010.203
Tuffaha, Haitham W., Treish, Imad M. and Zaru, Luna (2008). The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting. Journal of Oncology Pharmacy Practice, 14 (3), 131-8. doi: 10.1177/1078155208091249
Conference Papers
Grimm, S., Glynn, D., Coyle, D., Jalal, H., Koffijberg, E., Tuffaha, H., Vervaart, M., Welton, N.J., Wilson, E., Rothery, C. and Kunst, N. (2024). A roadmap to the use of value of information analysis in health technology assessment: an international study of barriers, facilitators, and potential applications. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17 – 20 November 2024. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2024.10.2049
Maraiki, F., Elhassan, T., Bazarbashi, S., Scuffham, P. and Tuffaha, H. (2024). Developing economic evaluation guidelines for Saudi Arabia – local experts engagement. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17 – 20 November 2024. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2024.10.2178
Teppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610
Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.
Green, Anna, Newton, Rob U., Chambers, Suzanne K., Smith, David P., Tuffaha, Haitham, Galvao, Daniel A., Heathcote, Peter, Patel, Manish I., Christie, David, Egger, Sam, Sara, Sally A. M., Heneka, Nicole and Dunn, Jeff (2024). Prostate cancer survivorship essentials for men with prostate cancer on androgen deprivation therapy: Protocol of an effectiveness-implementation hybrid (type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). COSA's 51st Annual Scientific Meeting: Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14117
Wang, Yufan, McCarthy, Sandie and Tuffaha, Haitham (2024). Is there sufficient evidence to implement prescribed exercise as standard cancer after-care? Insights to inform resource allocation using the value of information and implementation framework. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
Obermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551
Green, A., Newton, R. U., Chambers, S., Smith, D. P., Tuffaha, H., Galvao, D. A., Heathcote, P., Patel, M., Christie, D., Egger, S., Sara, S. A., Heneka, N. and Dunn, J. (2024). Early learnings from a national trial of a consumer and clinician developed survivorship care intervention for men with prostate cancer on androgen deprivation therapy (PCEssentials Hormone Therapy Study). World Cancer Congress, Geneva, Switzerland, 17–19 September 2024. Hoboken, NJ, United States: John Wiley & Sons.
Wang, Yufan, McCarthy, Alexandra L. and Tuffaha, Haitham (2023). Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer. HTAi 2023 Meeting, Adelaide, SA Australia, 24-28 June 2023. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/s0266462323001277
Green, Anna, Newton, Robert U., Chambers, Suzanne K., Smith, David P., Tuffaha, Haitham, Galvao, Daniel A., Heathcote, Peter, Patel, Manish, Christie, David, Egger, Sam, Sara, Sally, Heneka, Nicole and Dunn, Jeff (2023). Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol of an effectiveness-implementation hybrid (Type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials). 2023 ANZUP Annual Scientific Meeting, Melbourne, VIC, Australia, 9‐11 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13976
Gough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron Edward (2023). HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases. 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.e13561
Tuffaha, H., Arora, S., Denehy, L. and Edbrooke, L. (2022). How would the choice of the multi-attribute utility instrument affect the cost-effectiveness of cancer interventions? A comparison of the FACT-8D and the AQoL. ISPOR Europe 2022, Vienna, Austria, 6-9 November 2022. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2022.09.2001
Tuffaha, Haitham, Arora, Shiksha, Denehy, Linda and Edbrooke, Lara (2022). How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
Edmunds, Kim, Arora, Shiksha, Roberts, Matthew, Fairbairn, David, Scuffham, Paul, Smith, David, Chambers, Suzanne, Horvath, Lisa and Tuffaha, Haitham (2022). Genetic testing in prostate cancer: a scoping literature review. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
Wang, Yufan, McCarthy, Alexandra and Tuffaha, Haitham (2022). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
Edbrooke, Lara, Denehy, Linda, Patrick, Cameron and Tuffaha, Haitham (2021). Cost-effectiveness analysis of home-based rehabilitation in inoperable lung cancer. European-Respiratory-Society (ERS) International Congress, Thessaloniki Greece, Sep 26-30, 2021. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2021.OA4227
Edmunds, Kim, Scuffham, Paul, Newton, Rob U., Galvao, Daniel A. and Tuffaha, Haitham (2020). Exercise in preventing falls and fractures for men with prostate cancer receiving androgen deprivation therapy: a modelled cost-utility analysis. COSA Annual Scientific Meeting 2020, Virtual meeting, 11-13 November 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13497
Tuffaha, H., Radford, K., Chai, A., Rutherford, S., Harris, N. and Scuffham, P. (2020). PNS23 Setting health priorities in low-income and middle-income countries in the ASIA-Pacific region: the case of Papua New Guinea. ISPOR Asia Pacific 2020, Unknown, Unknown. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.vhri.2020.07.442
Edmunds, Kim, Tuffaha, Haitham, Reeves, Penny, Galvao, Daniel A., Newton, Robert U., Taaffe, Dennis R., Spry, Nigel and Scuffham, Paul (2019). Cost-effectiveness of exercise for prostate cancer patients with bone metastases – an exploratory study. Health services research association of Australia and New Zealand (HSRAANZ), Auckland, New Zealand, 4-6 December 2019.
Edmunds, Kim, Reeves, Penny, Tuffaha, Haitham, Galvao, Daniel A., Newton, Rob, Spry, Nigel, Denham, James, Taaffe, Dennis R., Joseph, David, Lamb, David S., Chambers, Suzanne K. and Scuffham, Paul (2019). Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation. COSA 46th Annual Scientific Meeting 2019, Adelaide, SA Australia, 12-14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262
Tuffaha, H. and Scuffham, P. (2019). PCN349 Value of information analysis guiding the reimbursement decision of olaparib for metastatic breast cancer. ISPOR Europe 2019, Copenhagen, Denmark, November 2019. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2019.09.544
Tuffaha, H. and Scuffham, P. (2019). PCN95 cost-effectiveness analysis of germline BRCA mutation testing and olaparib treatment in metastatic breast cancer: an evaluation of codependent technologies. ISPOR Europe 2019, Copenhagen, Denmark, 2-6 November 2019. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2019.09.292
Tuffaha, Haitham and Scuffham, Paul (2019). Value for money of putting precision into practice: Germline genetic testing to guide olaparib treatment in HER2-negative metastatic breast cancer. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, Australia, 12–14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262
Edmunds, Kim, Reeves, Penny, Tuffaha, Haitham, Galvao, Daniel, Newton, Rob, Spry, Nigel, Denham, James, Taaffe, Dennis R., Joseph, David, Lamb, David S., Chambers, Suzanne K. and Scuffham, Paul (2019). Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, SA, Australia, 12–14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262
Tuffaha, H., El-Saifi, N. and Scuffham, P. (2018). Value For Money, the Overlooked Aspect in Research Funding Decisions. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.413
Tuffaha, H. and Scuffham, P. (2018). Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.839
Tuffaha, Haitham, Chambers, Suzanne and Scuffham, Paul (2018). Can we prospectively assess the value for money of oncology clinical trials?. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, WA Australia, 13–15 November 2018. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.13089
El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Can technology improve medication adherence in older people with dementia?. 16th International Conference, ICOST 2018, Singapore, 10-12 July, 2018. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-94523-1_1
Maraiki, R., Bymes, J., Tuffaha, H. and Hider, M. (2017). INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCER. NEW YORK: ELSEVIER SCIENCE INC.
Maraiki, F., Byrnes, J., Tuffaha, H. and Hider, M. (2017). International HTA experience with targeted therapy approvals For lung cancer. ISPOR 20th Annual European Congress, Glasgow, United Kingdom, 4-8 November 2017. New York, NY USA: Elsevier. doi: 10.1016/j.jval.2017.08.335
Tuffaha, Haitham and Scuffham, Paul (2017). Improving patient access to novel cancer drugs in Australia: are we there yet?. COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Sydney, NSW Australia, 13-15 November 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
Gordon, Louisa, Tuffaha, Haitham, Scuffham, Paul and Lowe, Anthony (2015). Health economic modelling for treatments and services in prostate cancer care: a master model for Australia. 2nd Prostate Cancer World Congress (PCWC), Cairns, QLD, Australia, 17-21 August, 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13196
Tuffaha, H. W., Shelley, R., Chaboyer, W., Gordon, L. G. and Scuffham, P. A. (2014). COST-EFFECTIVENESS AND VALUE OF INFORMATION ANALYSES OF NUTRITIONAL SUPPORT IN PREVENTING PRESSURE ULCERS IN HIGH RISK HOSPITALISED PATIENTS. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jval.2014.08.2150
Tuffaha, H. W., Hussein, A. A. and Abdel-Rahman, F. A. (2012). COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTS. BMT Tandem Meeting, San Diego Ca, Feb 01-05, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.bbmt.2011.12.132
Tuffaha, H. W., Hussein, A. A., Sharma, S., Abu-Jazar, H., Al-Rawi, O. S., Saad, A. M., Al-Zaben, A., Hussein, N. and Abdel-Rahman, F. A. (2012). THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF +/- CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS. BMT Tandem Meeting, San Diego Ca, Feb 01-05, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.bbmt.2011.12.130
Najjar, R., Tuffaha, H., Abdel-Rahman, F., Hussein, A. and Jazar, H. A. (2012). Adverse drug reactions in bone marrow transplant patients. 38th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), Geneva, Switzerland, 1-4 April, 2012. London, United Kingdom: Nature Publishing Group. doi: 10.1038/bmt.2012.37
Generic Document
Thompson, Erik, Fraser, Susan and Tuffaha, Haitham (2021). Mammographic / Breast Density Facts and Issues. Clinical Oncology Society of Australia.
Research Reports
Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR). Canberra, ACT Australia: Commonwealth of Australia.
Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation. Canberra, ACT Australia: Commonwealth of Australia.
Hettiarachchi, Ruvini and Tuffaha, Haitham (2024). MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia. Canberra, ACT Australia: Commonwealth of Australia.
Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation. Canberra, ACT, Australia: Commonwealth of Australia.
Maguire, Angela M., Soole, Rebecca, Beilby, Hannah, Tabinga, Angeli, Barker, Natalie, Fear, Nicola T., Kenardy, Justin, Tuffaha, Haitham and Khoo, Andrew (2023). Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment. Canberra, ACT Australia: Commonwealth of Australia.
Edmunds, K., Hettiarachchi, R., Teppala, S., Shiksha, A., Madeline, O. and Tuffaha, H. (2023). (November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.
Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.
Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.
Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.
Hettiarachchi, R. and Tuffaha, H. (2023). (April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT. Canberra, ACT, Australia: Commonwealth of Australia.
Edmunds, Kim and Tuffaha, Haitham (2022). Validation of Strokenomics Budget Impact Model for Stryker stent-based mechanical thrombectomy for acute ischaemic stroke. Brisbane, QLD Australia: The University of Queensland.
Tuffaha, Haitham, Birch, Stephen and Oakley, Padraig (2022). Assessing the impact of clinical trials: a scoping literature review. Melbourne, VIC Australia: Australian Clinical Trials Alliance.
Tuffaha, Haitham and Birch, Stephen (2022). A pilot study to prospectively estimate the health and economic return on research investment. Melbourne, VIC Australia: Australian Clinical Trials Alliance.
Tuffaha, Haitham and Birch, Stephen (2021). Estimating the return on investment of a randomised controlled trial on telehealth-based medical nutrition intervention in rural and regional Australia. Armidale, NSW, Australia: Spinifex Network.
Tuffaha, Haitham, Morton, Rachael and Cumpston, Miranda (2020). ACTA Research Prioritisation Framework. Melbourne, VIC, Australia: Australian Clinical Trials Alliance.
Vecchio, Nerina, Tuffaha, Haitham, Radford, Katrina and Chai, Andreas (2018). Implementation of GCPHN Evaluation Framework – COPD After Hours and Persistent Pain Program. Gold Coast, QLD, Australia: Griffith University.
Gordon, Louisa, Tuffaha, Haitham, James, Robbie and Scuffham, Paul (2016). Economic modelling of healthcare services for prostate cancer. Monographs in Prostate Cancer St Leonards, NSW, Australia: Prostate Cancer Foundation of Australia.
Tuffaha, Haitham, Gordon, Louisa and Scuffham, Paul (2015). Transient elastography at 50Hz for the diagnosis of liver fibrosis in patients with hepatitis B or C: MSAC Assessment Report. Canberra, ACT Australia: Department of Health.
Gordon,Louisa, Sowa,M, Tuffaha, Haitham and Scuffham, Paul (2014). Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment. Canberra, ACT, Australia: Commonwealth of Australia.
Theses
Tuffaha, Haitham (2016). Value of Information Analysis Applications in Healthcare Interventions. PhD Thesis, School of Medicine , Griffith University. doi: 10.25904/1912/3508
Tuffaha, Haitham (2005). Implementation and validation of a method for characterising prescribing activity and associated pharmaceutical activity in haematology setting. M.Sc Thesis, School of Pharmacy, University of Strathclyde.